Impact Factor: 2.094 (Source: 2015 Thomson Reuters, Journal Citation Reports). Journal Ranking: 150/213 (Oncology) - (Source: Publisher) Circulation: The Publisher does not disclose the circulation. Aims of the Journal: Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. Content: Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: - Expert Commentary: a personal view on the most effective or promising strategies - Five-year view: a clear perspective of future prospects within a realistic time-scale - Key issues: an executive summary cutting to the author's most critical points Readership: The journal is aimed at doctors and Health professionals working in Oncology mainly. Manuscript Submission: Articles published in the journal are commissioned by the Editor in collaboration with the Editorial Advisory Board. All articles are subject to rigorous peer-review. Author guidelines can be found here. Online manuscripts submission can be found here. Ad Rates: Advertising information can be found here.

Impact Factor: 2.596 (Source: Publisher) Journal Ranking: 83/150 (Immunology) (Source: 2015 Journal Citation Reports, Thomson Reuters 2016) Circulation: The figure is not currently disclosed. Frequency: Published 12 times a year. Aims of the journal: Expert Review of Clinical Immunology aims to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Content: Articles focus on the following key areas: Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines Performance and benefits of newly approved therapeutic agents New diagnostic approaches Screening and patient stratification Pharmacoeconomic studies New therapeutic indications for existing therapies Adverse effects, occurrence and reduction Prospects for medicines in late-stage trials approaching regulatory approval Novel treatment strategies Epidemiological studies Commentary and comparison of treatment guidelines Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases. Editorial contacts: See the full list of editorial contacts here Manuscript Submission: See author guidelines here Access online submission portal here Other information: To discuss advertising & sponsorship needs, contact Per Sonnerfeldt at per.sonnerfeldt@informa.com.

Impact factor: 2.488 (2015) Circulation: The Publisher does not disclose the circulation Frequency: Bi-monthly Aims of the journal: Clinical pharmacology aims to provide an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice. Expert Review of Clinical Pharmacology provides a forum for informed debate and critical analysis of all aspects of safety, tolerability, efficacy and therapeutic applications, in addition to covering toxicity issues, adverse reactions, pharmacoeconomics and societal issues. Content: Coverage includes: ADME studies and PK/PD modeling Novel clinical trial design and conduct Toxicity and carcinogenesis Adverse effects/reactions, drug–drug and drug–disease interactions Pharmacogenetics, genomics and the incorporation of new biomarkers in drug development and clinical practice Translational medicine Pharmacoepidemiology, risk management and pharmacovigilance Pharmacotherapy in specific patient groups, such as children, women, the immunocompromised Pharmacology and ethnicity Impact on quality of life and pharmacoeconomic issues Regulation of drug development and marketing Epidemiology and biostatistics Readership: The journal is aimed at clinical and pharmaceutical researchers, drug development specialists, physicians and other healthcare professionals with the key information they need to assist in the progress of pharmacological therapy. Manuscript submission: Contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Instructions for authors can be viewed here Online manuscripts submission can be found here For authors preparing Drug Profiles or Clinical Trial Commentaries, please contact Mary Yianni for article-specific guidelines.

Impact factor: 0.49 (Source: SJR) Circulation: The Publisher does not disclose the circulation Frequency: Published 6 times a year. Aims of the journal: Expert Review of Endocrinology and Metabolism, provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology. It aims to serve all professionals within this speciality, encompassing topics in clinical diseases such as diabetes, osteoporosis, thyroid disease, adrenal insufficiency and pituitary tumors, as well as disorders associated with growth, reproduction, weight management and hormone-regulated gene expression. Content: Comprehensive coverage is augmented by: Expert commentary - a personal opinion on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical points Editorial Contacts: Please see the list of editorial contacts here.   Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here. Online manuscripts submission can be found here.

Impact Factor: 2.546 Journal Ranking: 33/74 (Gastroenterology & Hepatology) Circulation: The Publisher does not disclose the circulation Frequency: Bi-monthly Aims of the journal: Expert Review of Gastroenterology & Hepatology provides comprehensive coverage of state-of-the-art research and clinical advancements in the field as they occur. The journal focuses on the latest advances in our pathological, biochemical and physiological understanding of the diseases affecting the gastrointestinal tract and liver, in addition to up-to-the-minute developments in strategies for prevention, diagnosis and intervention. Content: Article coverage includes the following key areas: Latest advances in pathological, biochemical and physiological understanding of the diseases of the digestive system and its associated organs Developments in investigative strategies; such as radiology, endoscopy, cholangiopancreatography, colonoscopy and liver biopsy Advances in molecular diagnosis and biomarker research Recent developments in pharmacological approaches and emerging therapeutics Drug safety Disease-specific reviews, including coverage of digestive cancers, hepatitis infections, liver cirrhosis, inflammatory bowel disease, functional gastrointestinal disorder, and biliary and gall bladder disease Optimal management of pediatric digestive diseases, with regard to diagnosis and issues, such as absorption, nutrition and growth Psychosocial aspects Pharmacoeconomics and outcomes research, supplemented by cost–benefit analysis Readership: The journal is aimed at doctors and health professionals working in the Gastroenterology & Hepatology area Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here Online manuscripts submission can be found here

Impact Factor: 2.439 Journal Ranking: 40/70 in Hematology (Thomson Reuters Journal Citation Reports 2015) Circulation: The Publisher does not disclose the circulation Aims of the journal: Expert Review of Hematology provides commentary and analysis to elucidate best clinical practice in hematology and to translate advances in research - in areas such as immunology, stem cell research, and cell and gene therapy – into the clinical context. Content: Areas covered include: Acute leukemias Anemias Bleeding disorders Bone marrow and hematopoietic stem cell transplantation Cellular disorders Chronic leukemias Disorders of iron metabolism Hodgkins disease. Infection in hematology Immunodeficiency syndromes Autoimmune diseases Marrow failure syndromes Multiple myeloma and amyloidosis Neutropenia Non-Hodgkin lymphomas Pediatric hematology Platelet disorders Thrombosis and hemostasis Transfusion medicine Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here Online manuscripts submission can be found here

Impact Factor: 1.796 Journal Ranking: 40/76 (source: Engineering, Biomedical) Circulation: The Publisher does not disclose the circulation Frequency: Monthly Aims of the journal: Expert Review of Medical Devices provides commentary, analysis and debate for all professionals involved in research, development, testing and clinical use of devices. In addition to the Review program, each issue also features Medical Device Profiles - objective assessments of specific devices in development or clinical use to help inform clinical practice. Content: Comprehensive coverage by each author in a key area of research or clinical practice is augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical point Readership: The journal serves the device research community by providing a comprehensive body of high-quality information from leading experts, all subject to rigorous peer-review. Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Ad Rates: Advertising information can be found here Other information: Author guidelines can be found here. Online manuscripts submission can be found here. 

Impact factor: 3.333 (© 2015 Thomson Reuters, Journal Citation Reports®) Journal Ranking: 16/76 (Pathology). Circulation: The publishers do not release circulation figures. Aims of the journal: Expert Review of Molecular Diagnostics aims to publish reviews of the latest advancements in the field of molecular diagnostics. Each issue contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process. These reviews include: editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations reviewing recently published articles carefully selected and assessed by specialists in molecular diagnostic therapy. Content: Key areas of coverage include: Application of technological advances in molecular diagnostic medicine Latest discoveries in oncology diagnostics Biomarker usage to guide drug development and target patient groups for personalized medicine Emerging 'omic diagnostic technologies including: pharmacogenomic, epigenomic, proteomic and metabolomic technologies Molecular tools for infectious disease testing Disease predisposition and inherited genetic diseases testing and monitoring Development and improvement of current molecular diagnostics tests Tracking of drug-diagnostic co-developments Regulatory, ethical and payor perspectives in molecular diagnostics Manuscript submission: Guidelines for authors can be found here Online manuscripts submission can be found  Normal 0 false false false EN-GB X-NONE X-NONE MicrosoftInternetExplorer4 <w:LsdException Locked="false" Priority="9" QFormat="true"

Impact Factor: 3.085 (source: 2013 ISI Impact Factor) Journal Ranking: Unavailable Circulation: The Publisher does not disclose the circulation Frequency: Bi-monthly Aims of the journal: Expert Review of Ophthalmology provides an important platform for commentary and debate on current and emerging approaches in ocular medicine. The worldwide problem of visual impairment is set to increase, as we are seeing increased longevity in developed countries. This will produce a crisis in vision care unless concerted action is taken. Although there are as many as 37 million people suffering with blindness throughout the world, 80% of vision loss is either preventable or treatable.The substantial value that ophthalmic interventions confer to patients with eye diseases has led to intense research efforts in this area in recent years, with corresponding improvements in treatment, ophthalmic instrumentation and surgical techniques. As a result, the future for ophthalmology holds great promise as further exciting and innovative developments unfold. Readership: Expert Review of Ophthalmology provides the ophthalmic community with a critical mass of structured information from the international opinion leaders, with all articles subject to rigorous peer review. Content: Coverage includes: Therapeutic approaches in ophthalmic disorders Visual function and optics Ocular tumors Surgical techniques & interventional approaches New instruments Advanced materials, prostheses & devices Oculoplastics Neuro-ophthalmology Ocular manifestations of systemic disease Molecular biology & molecular genetics in ophthalmology Epidemiologic studies Management of ocular infections and inflammation Pharmacoeconomics and quality of life studies Comprehensive coverage in each review is complemented by the unique Expert Review article format, which includes: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical points Annotated references - indicating the relevance and importance of cited articles Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines can be found here Online manuscripts submission can be found at mc.manuscriptcentral.com/expertreviews

Impact Factor: 1.631 (Source: 2015 Thomson Reuters, Journal Citation Reports) Journal Ranking: 39/82 (Healthcare) Circulation: The Publisher does not disclose the circulation figure.  Frequency: Six issues per year  Aims of the journal: Expert Review of Pharmacoeconomics & Outcomes Research provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review.  Content: The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical points Editorial Contacts: The editorial board can be viewed here.  Manuscript submission: Unsolicited manuscripts are accepted for publication in the journal; please contact the Commissioning Editor with a brief proposal and article outline. All articles are subject to rigorous peer-review. Author guidelines and instructions for submissions can be viewed here.